Cardiff Oncology: Q2 Earnings Snapshot
By AP News
Published - Aug 08, 2024, 05:04 PM ET
Last Updated - Aug 08, 2024, 05:04 PM EDT
SAN DIEGO (AP) — SAN DIEGO (AP) — Cardiff Oncology, Inc. (CRDF) on Thursday reported a loss of $11.8 million in its second quarter.
The San Diego-based company said it had a loss of 26 cents per share.
The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 25 cents per share.
The molecular diagnostic company posted revenue of $163,000 in the period.
